Literature DB >> 15516841

The Jewish people: their ethnic history, genetic disorders and specific cancer susceptibility.

Inbal Kedar-Barnes1, Paul Rozen.   

Abstract

The Jews are an ancient and unique group of people linked by language, religion and customs in spite of their major geographical shifts, expulsions, forced conversions and massacres throughout their entire history. As a result of these historical events that led to repeated migration, the Jewish people became dispersed into various ethnic sub-groups. Between these ethnic groups exists heterogeneity, as well as some similarities, to the populations amongst whom they lived. Rare genetic diseases have been reported to be prevalent among the different groups of Jews, which for the most part can be explained by random genetic drift together with intra-familial marriages. In this publication, we will briefly discuss the origin of the various ethnic groups and some of the genetic diseases commonly found in them, with emphasis on the Ashkenazim, their prevalent genetic diseases and cancer susceptibility.

Entities:  

Mesh:

Year:  2004        PMID: 15516841     DOI: 10.1007/s10689-004-9544-0

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  30 in total

1.  Jewish and Middle Eastern non-Jewish populations share a common pool of Y-chromosome biallelic haplotypes.

Authors:  M F Hammer; A J Redd; E T Wood; M R Bonner; H Jarjanazi; T Karafet; S Santachiara-Benerecetti; A Oppenheim; M A Jobling; T Jenkins; H Ostrer; B Bonne-Tamir
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  The Y chromosome pool of Jews as part of the genetic landscape of the Middle East.

Authors:  A Nebel; D Filon; B Brinkmann; P P Majumder; M Faerman; A Oppenheim
Journal:  Am J Hum Genet       Date:  2001-09-25       Impact factor: 11.025

3.  Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.

Authors:  Neil Risch; Hua Tang; Howard Katzenstein; Josef Ekstein
Journal:  Am J Hum Genet       Date:  2003-02-24       Impact factor: 11.025

4.  The possibility of a selection process in the Ashkenazi Jewish population.

Authors:  Joel Zlotogora; Gideon Bach
Journal:  Am J Hum Genet       Date:  2003-08       Impact factor: 11.025

5.  Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.

Authors:  S Neuhausen; T Gilewski; L Norton; T Tran; P McGuire; J Swensen; H Hampel; P Borgen; K Brown; M Skolnick; D Shattuck-Eidens; S Jhanwar; D Goldgar; K Offit
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

6.  Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.

Authors:  S J Laken; G M Petersen; S B Gruber; C Oddoux; H Ostrer; F M Giardiello; S R Hamilton; H Hampel; A Markowitz; D Klimstra; S Jhanwar; S Winawer; K Offit; M C Luce; K W Kinzler; B Vogelstein
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

7.  A636P is associated with early-onset colon cancer in Ashkenazi Jews.

Authors:  José G Guillem; Beth S Rapaport; Tomas Kirchhoff; Prema Kolachana; Khedoudja Nafa; Emily Glogowski; Rob Finch; Helen Huang; William D Foulkes; Arnold Markowitz; Nathan A Ellis; Kenneth Offit
Journal:  J Am Coll Surg       Date:  2003-02       Impact factor: 6.113

Review 8.  Fanconi anemia and leukemia: tracking the genes.

Authors:  A D Auerbach
Journal:  Leukemia       Date:  1992       Impact factor: 11.528

9.  A prospective study of the clinical, genetic, screening, and pathologic features of a family with hereditary mixed polyposis syndrome.

Authors:  P Rozen; Z Samuel; E Brazowski
Journal:  Am J Gastroenterol       Date:  2003-10       Impact factor: 10.864

10.  An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome.

Authors:  E E M Jaeger; K L Woodford-Richens; M Lockett; A J Rowan; E J Sawyer; K Heinimann; P Rozen; V A Murday; S C Whitelaw; A Ginsberg; W S Atkin; H T Lynch; M C Southey; H Debinski; C Eng; W F Bodmer; I C Talbot; S V Hodgson; H J W Thomas; I P M Tomlinson
Journal:  Am J Hum Genet       Date:  2003-04-14       Impact factor: 11.025

View more
  6 in total

1.  Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population.

Authors:  Steven M Bray; Jennifer G Mulle; Anne F Dodd; Ann E Pulver; Stephen Wooding; Stephen T Warren
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-26       Impact factor: 11.205

2.  The impact of nativity on chronic diseases, self-rated health and comorbidity status of Asian and Hispanic immigrants.

Authors:  Jimi Huh; Jo Ann Prause; C David Dooley
Journal:  J Immigr Minor Health       Date:  2008-04

Review 3.  Pharmacogenetics in Jewish populations.

Authors:  Yao Yang; Inga Peter; Stuart A Scott
Journal:  Drug Metabol Drug Interact       Date:  2014

4.  Trends in colorectal cancer incidence and mortality in the Israeli Jewish ethnic populations.

Authors:  Micha Barchana; Irena Liphshitz; Paul Rozen
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

5.  Genomes, populations and diseases: ethnic genomics and personalized medicine.

Authors:  V A Stepanov
Journal:  Acta Naturae       Date:  2010-10       Impact factor: 1.845

6.  Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping.

Authors:  Adam B Olshen; Bert Gold; Kirk E Lohmueller; Jeffery P Struewing; Jaya Satagopan; Stefan A Stefanov; Eleazar Eskin; Tomas Kirchhoff; James A Lautenberger; Robert J Klein; Eitan Friedman; Larry Norton; Nathan A Ellis; Agnes Viale; Catherine S Lee; Patrick I Borgen; Andrew G Clark; Kenneth Offit; Jeff Boyd
Journal:  BMC Genet       Date:  2008-02-05       Impact factor: 2.797

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.